Company news

Precision BioSciences, Inc. news in 2022

Precision BioSciences, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Precision BioSciences Announces Change to its Board of Directors

November 9, 2022

Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update

November 7, 2022

Precision BioSciences Announces Data Presentation on Effective Cell Dose and Functional Attributes of CD19 Allogeneic CAR T, Azer-Cel, at the Upcoming 2022 American Society of Hematology (ASH) Annual Meeting

November 2, 2022

Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022

November 1, 2022

Precision BioSciences Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)

October 25, 2022

Precision BioSciences Announces Senior Leadership Organizational Changes

September 1, 2022

Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update

August 7, 2022

Precision BioSciences to Report Second Quarter 2022 Financial Results on August 8, 2022

July 31, 2022

Precision BioSciences Announces Closing of Underwritten Offering of Common Stock

June 26, 2022

Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell Disease

June 20, 2022

Precision BioSciences Announces $50 Million Offering of Common Stock

June 20, 2022

Precision BioSciences Provides Update on Allogeneic CAR T Programs and Path Forward with Its Lead PBCAR0191 Candidate for CAR T Relapsed Patient Population

June 7, 2022

Precision BioSciences to Provide an Update on its Ongoing Allogeneic CAR T Programs via Hosted Virtual Webcast and Conference Call on Wednesday, June 8, 2022

June 2, 2022

Precision BioSciences Appoints Melinda Brown to Board of Directors

May 30, 2022

Precision BioSciences Appoints Juli Blanche as Chief People Officer

May 22, 2022

Precision BioSciences Announces Publication in Molecular Therapy of ARCUS® In Vivo Gene Editing as a Promising Therapeutic Approach to Cure Chronic Hepatitis B Infection

May 17, 2022

Precision BioSciences Announces Preclinical Data Showcasing Premier In Vivo Gene Editing Capabilities at American Society of Gene & Cell Therapy Annual Meeting

May 15, 2022

Precision BioSciences Reports First Quarter 2022 Financial Results and Provides Business Update

May 8, 2022

Precision BioSciences to Report First Quarter 2022 Financial Results on May 9, 2022

May 1, 2022

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update

March 14, 2022

Decks in 2022